Anthropic CEO Dario Amodei on Monday laid out the startup’s vision for how AI could solve problems in healthcare and the life sciences, from speeding up drug approvals by streamlining clinical trial ...

Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Friday, Aurora Therapeutics debuted with $16 million in seed capital from Menlo Ventures. Its goal: To develop the industry’s ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

A notable surge in investment activity has emerged around Intellia Therapeutics, with significant share acquisitions by both ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

If I were to locate the moment AI slop broke through into popular consciousness, I’d pick the video of rabbits bouncing on a ...